NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Talkspace (Nasdaq: TALK), a leading behavioral healthcare company, today announced that Jon R. Cohen, M.D., CEO, and Jennifer Fulk, CFO, will present and host one-on-one investor meetings at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on January 11, 2024. The Company’s presentation will be at 8:15am PST.

A webcast and presentation materials will be available on Talkspace’s Investor Relations Website: https://investors.talkspace.com/.

To schedule a one-on-one meeting with Dr. Cohen and Ms. Fulk, please contact your J.P. Morgan representative.

About Talkspace

Talkspace (Nasdaq: TALK) is a leading virtual behavioral healthcare company committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to overall healthcare and should be available to everyone.

Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services from self-guided products to individual and couples therapy, in addition to psychiatric treatment and medication management. With Talkspace’s core psychotherapy offering, members are matched with one of thousands of licensed providers across all 50 states and can choose from a variety of subscription plans including live video, text or audio chat sessions and/or asynchronous text messaging.

All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Talkspace covers approximately 113 million lives as of September 30, 2023, through our partnerships with employers, health plans, and paid benefits programs.

For more information, visit www.talkspace.com.

Contacts

‍For Investors:
Neal Nagaragan
Sloane & Company
(301) 273-5662
This email address is being protected from spambots. You need JavaScript enabled to view it. 

For Media:
John Kim
SKDK
(310) 997-5963 
This email address is being protected from spambots. You need JavaScript enabled to view it.